Perceived risk profile and treatment optimization in heart failure: an analysis from BIOlogy Study to TAilored Treatment in chronic heart failure

BACKGROUND: Achieving target doses of angiotensin‐converting‐enzyme inhibitor/angiotensin‐receptor blockers (ACEi/ARB) and beta‐blockers in heart failure with reduced ejection fraction (HFrEF) is often underperformed. In BIOlogy Study to TAilored Treatment in chronic heart failure (BIOSTAT‐CHF) stud...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cardiol
Main Authors: Kobayashi, Masatake, Voors, Adriaan A., Ouwerkerk, Wouter, Duarte, Kevin, Girerd, Nicolas, Rossignol, Patrick, Metra, Marco, Lang, Chim C., Ng, Leong L., Filippatos, Gerasimos, Dickstein, Kenneth, van Veldhuisen, Dirk J., Zannad, Faiez, Ferreira, João Pedro
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley Periodicals, Inc. 2021
Assuntos:
Clinical Investigations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8207977/
https://ncbi.nlm.nih.gov/pubmed/33960439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.23576
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados